32.03
+0.34(+1.07%)
Currency In USD
| Previous Close | 31.69 |
| Open | 31.86 |
| Day High | 32.13 |
| Day Low | 31.58 |
| 52-Week High | 34.2 |
| 52-Week Low | 24.05 |
| Volume | 2.96M |
| Average Volume | 4.63M |
| Market Cap | 13.88B |
| PE | 16.77 |
| EPS | 1.91 |
| Moving Average 50 Days | 32.58 |
| Moving Average 200 Days | 28.88 |
| Change | 0.34 |
If you invested $1000 in Royalty Pharma plc (RPRX) since IPO date, it would be worth $793.8 as of April 25, 2025 at a share price of $32.03. Whereas If you bought $1000 worth of Royalty Pharma plc (RPRX) shares 3 years ago, it would be worth $811.5 as of April 25, 2025 at a share price of $32.03.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Royalty Pharma Declares Second Quarter 2025 Dividend
GlobeNewswire Inc.
Apr 21, 2025 8:15 PM GMT
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the second quarter of 2025 of $0.22 per Class A ordinary share. The dividend will be paid on June 10
Royalty Pharma to Announce First Quarter 2025 Financial Results on May 8, 2025
GlobeNewswire Inc.
Apr 17, 2025 8:15 PM GMT
NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its first quarter 2025 financial results on Thursday, May 8, 2025 before the U.S. financial markets open. The company will host a con
Royalty Pharma Appoints Vlad Coric, M.D. to the Company’s Board of Directors
GlobeNewswire Inc.
Apr 08, 2025 8:15 PM GMT
NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Vlad Coric, M.D. to the company’s Board of Directors, effective immediately. Vlad Coric is the Chairman and Chief Executive Officer of